爱博医疗：龙晶PR产品打破了进口产品在该领域的垄断格局

Group 1 - The core viewpoint of the article highlights that Aibo Medical's Longjing® PR product is leading in the domestic market, breaking the monopoly of imported products in its field due to its excellent optical performance, good biocompatibility, and diverse model adaptations [2] Group 2 - Aibo Medical responded to investor inquiries on an interactive platform, emphasizing the competitive advantages of its Longjing® PR product [2] - The product's attributes are positioned as superior to those of imported alternatives, indicating a significant shift in market dynamics [2] - The company aims to establish a strong foothold in the domestic market by leveraging its innovative product features [2]